| Product Code: ETC9971146 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Narcolepsy Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Narcolepsy Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Narcolepsy Market - Industry Life Cycle |
3.4 United States (US) Narcolepsy Market - Porter's Five Forces |
3.5 United States (US) Narcolepsy Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.6 United States (US) Narcolepsy Market Revenues & Volume Share, By Therapeutics, 2021 & 2031F |
4 United States (US) Narcolepsy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about narcolepsy among healthcare providers and patients |
4.2.2 Rising prevalence of narcolepsy in the United States |
4.2.3 Technological advancements in diagnostic tools and treatment options for narcolepsy |
4.3 Market Restraints |
4.3.1 High cost associated with narcolepsy diagnosis and treatment |
4.3.2 Limited availability of approved medications for narcolepsy treatment |
4.3.3 Stigma and misconceptions surrounding narcolepsy leading to delayed diagnosis and treatment |
5 United States (US) Narcolepsy Market Trends |
6 United States (US) Narcolepsy Market, By Types |
6.1 United States (US) Narcolepsy Market, By Disease |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Narcolepsy Market Revenues & Volume, By Disease, 2021- 2031F |
6.1.3 United States (US) Narcolepsy Market Revenues & Volume, By Daytime Extreme Sleepiness, 2021- 2031F |
6.1.4 United States (US) Narcolepsy Market Revenues & Volume, By Cataplexia, 2021- 2031F |
6.1.5 United States (US) Narcolepsy Market Revenues & Volume, By Other Disease Type, 2021- 2031F |
6.2 United States (US) Narcolepsy Market, By Therapeutics |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Narcolepsy Market Revenues & Volume, By Central Nervous System Stimulants, 2021- 2031F |
6.2.3 United States (US) Narcolepsy Market Revenues & Volume, By Tricyclic Antidepressants, 2021- 2031F |
6.2.4 United States (US) Narcolepsy Market Revenues & Volume, By Sodium Oxybate, 2021- 2031F |
6.2.5 United States (US) Narcolepsy Market Revenues & Volume, By Selective Serotonin Reuptake Inhibitor, 2021- 2031F |
6.2.6 United States (US) Narcolepsy Market Revenues & Volume, By Other Therapeutic Type, 2021- 2031F |
7 United States (US) Narcolepsy Market Import-Export Trade Statistics |
7.1 United States (US) Narcolepsy Market Export to Major Countries |
7.2 United States (US) Narcolepsy Market Imports from Major Countries |
8 United States (US) Narcolepsy Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis of narcolepsy |
8.2 Number of healthcare professionals trained in narcolepsy diagnosis and treatment |
8.3 Patient adherence to prescribed narcolepsy treatment plan |
8.4 Number of clinical trials for new narcolepsy medications |
8.5 Patient-reported outcomes related to narcolepsy symptom management |
9 United States (US) Narcolepsy Market - Opportunity Assessment |
9.1 United States (US) Narcolepsy Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.2 United States (US) Narcolepsy Market Opportunity Assessment, By Therapeutics, 2021 & 2031F |
10 United States (US) Narcolepsy Market - Competitive Landscape |
10.1 United States (US) Narcolepsy Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Narcolepsy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here